Plus Therapeutics

OverviewSuggest Edit

Plus Therapeutics (formerly known as Cytori Therapeutics) is a pharmaceutical company focused on the discovery, development, and manufacturing of treatments for patients battling cancer and other life-threatening diseases. The company delivers a range of drugs using liposomal encapsulation technology.
TypePublic
Founded1996
HQAustin, TX, US
Websiteplustherapeutics.com
Employee Ratings2.9

Latest Updates

Employees (est.) (Dec 2020)12
Revenue (FY, 2019)$7 M(+91%)
Share Price (May 2022)$0.5(+5%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Plus Therapeutics

Marc Hedrick

Marc Hedrick

President and CEO
Andrew Sims

Andrew Sims

Vice President and Chief Financial Officer
Cheri Rice

Cheri Rice

Vice President, Product Development
Norman Lafrance

Norman Lafrance

Chief Medical Officer and Senior Vice President
Russ Havranek

Russ Havranek

Vice President, Corporate Strategy and New Product Planning
Richard Hawkins

Richard Hawkins

Chairman
Show more

Plus Therapeutics Office Locations

Plus Therapeutics has offices in Austin and San Antonio
Austin, TX, US (HQ)
4200 Marathon Blvd #200
San Antonio, TX, US
12500 Network Blvd
Show all (2)

Plus Therapeutics Financials and Metrics

Plus Therapeutics Revenue

Plus Therapeutics's revenue was reported to be $7 m in FY, 2019 which is a 90.6% increase from the previous period.
USD

Net income (Q1, 2021)

(2.7m)

EBIT (Q1, 2021)

(2.5m)

Market capitalization (13-May-2022)

7.4m

Closing stock price (13-May-2022)

0.5

Cash (31-Mar-2021)

14.4m

EV

(517.6k)
Plus Therapeutics's current market capitalization is $7.4 m.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

6.4m3.7m7.0m

Revenue growth, %

(43%)91%

Cost of goods sold

1.3m1.1m

Gross profit

5.1m2.5m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

1.6m1.6m1.3m1.4m302.0k4.8m118.0k185.0k

Cost of goods sold

273.0k324.0k322.0k353.0k

Gross profit

1.4m1.2m990.0k1.1m

Gross profit Margin, %

83%79%75%75%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

9.6m5.3m17.6m8.3m

Accounts Receivable

145.0k286.0k1.2m

Inventories

3.2m2.9m107.0k

Current Assets

14.9m9.6m19.8m9.2m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

5.9m3.1m6.8m3.9m4.5m16.8m16.1m9.3m7.6m14.4m

Accounts Receivable

769.0k399.0k440.0k455.0k80.0k4.8m978.0k951.0k

Inventories

3.2m3.0m2.8m3.0m107.0k107.0k107.0k107.0k107.0k

Current Assets

10.7m7.4m10.8m8.5m5.3m22.3m17.7m10.8m8.6m15.4m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(22.7m)(12.6m)(10.9m)(8.2m)

Depreciation and Amortization

2.2m2.0m896.0k366.0k

Inventories

251.0k475.0k259.0k

Accounts Payable

(1.8m)(1.5m)(28.0k)(1.2m)
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(4.4m)(8.1m)(10.4m)(3.1m)(12.3m)(11.8m)(1.1m)(2.9m)(4.7m)(2.7m)

Depreciation and Amortization

497.0k975.0k1.5m443.0k617.0k778.0k94.0k188.0k273.0k88.0k

Inventories

141.0k371.0k615.0k16.0k235.0k274.0k

Accounts Payable

(556.0k)(1.2m)(1.3m)(405.0k)(94.0k)(95.0k)410.0k371.0k(1.6m)(461.0k)
USDFY, 2017

Revenue/Employee

173.3k

Debt/Equity

1 x

Debt/Assets

0.4 x

Financial Leverage

2.4 x
Show all financial metrics

Plus Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Plus Therapeutics Online and Social Media Presence

Embed Graph

Plus Therapeutics News and Updates

Plus Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights

First patient dosed in ReSPECT-LM Phase 1/2a dose escalation trial of 186RNL for leptomeningeal metastases

Plus Therapeutics Announces Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting

AUSTIN, Texas, April 19, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that it will discuss new data in an oral pres…

Plus Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting

AUSTIN, Texas, April 08, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that the company will present a poster at the…

Plus Therapeutics and Medidata Announce Expanded Clinical Trial Partnership

Companies collaborate to design innovative registrational trial of 186RNL for recurrent glioblastoma

Plus Therapeutics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

AUSTIN, Texas, March 23, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced today that Marc Hedrick, M.D., President and Chief Executive O…

Plus Therapeutics Announces First Patient Dosed in Phase 1/2a Dose Escalation Trial of 186RNL Radiotherapeutic for Leptomeningeal Metastases

ReSPECT-LM trial to evaluate safety/tolerability and identify MTD/MFD in three cohorts
Show more

Plus Therapeutics Frequently Asked Questions

  • When was Plus Therapeutics founded?

    Plus Therapeutics was founded in 1996.

  • Who are Plus Therapeutics key executives?

    Plus Therapeutics's key executives are Marc Hedrick, Andrew Sims and Cheri Rice.

  • How many employees does Plus Therapeutics have?

    Plus Therapeutics has 12 employees.

  • Who are Plus Therapeutics competitors?

    Competitors of Plus Therapeutics include Praedicare Labs, Allogene Therapeutics and AVEO Pharmaceuticals.

  • Where is Plus Therapeutics headquarters?

    Plus Therapeutics headquarters is located at 4200 Marathon Blvd #200, Austin.

  • Where are Plus Therapeutics offices?

    Plus Therapeutics has offices in Austin and San Antonio.

  • How many offices does Plus Therapeutics have?

    Plus Therapeutics has 2 offices.